Related references
Note: Only part of the references are listed.Behavior of CD34+ cells isolated from patients with polycythemia vera in NOD/SCID mice
Takefumi Ishii et al.
EXPERIMENTAL HEMATOLOGY (2007)
The JAK2 617V>F mutation triggers erythropoietin hypersensitivity and terminal erythroid amplification in primary cells from patients with polycythemia vera
Sabrina Dupont et al.
BLOOD (2007)
Studies of c-Mpl function distinguish the replication of hematopoietic stem cells from the expansion of differentiating clones
Janis L. Abkowitz et al.
BLOOD (2007)
In vitro expansion of erythroid progenitors from polycythemia vera patients leads to decrease in JAK2V617F allele
Amos Gaikwad et al.
EXPERIMENTAL HEMATOLOGY (2007)
Evidence that the JAK2 G1849T (V617F) mutation occurs in a lymphomyeloid progenitor in polycythemia vera and idiopathic myelofibrosis
Francois Delhommeau et al.
BLOOD (2007)
The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera
Eric Lippert et al.
BLOOD (2006)
New insights into the pathogenesis of JAK2 V617F-positive myeloproliferative disorders and consequences for the management of patients
Jean-Luc Villeval et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2006)
Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction
Mhairi Copland et al.
BLOOD (2006)
The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation
CHM Jamieson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Expression of a homodimeric type I cytokine receptor is required for JAK2V617F-mediated transformation
XH Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Bcr-Abl-mediated suppression of normal hematopoiesis in leukemia
H Lin et al.
ONCOGENE (2005)
A gain-of-function mutation of JAK2 in myeloproliferative disorders
R Kralovics et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
RL Levine et al.
CANCER CELL (2005)
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
EJ Baxter et al.
LANCET (2005)
Different subsets of primary chronic myeloid leukemia stem cells engraft immunodeficient mice and produce a model of the human disease
W Eisterer et al.
LEUKEMIA (2005)
The constitutive mobilization of bone marrow-repopulating cells into the peripheral blood in idiopathic myelofibrosis
MJ Xu et al.
BLOOD (2005)
Prominent role of TGF-β1 in thrombopoietin-induced myelofibrosis in mice
H Chagraoui et al.
BLOOD (2002)
Share Paper
